You are here

diabetes

Why Tandem Diabetes Care Stock Took It on the Chin Tuesday

Motley Fool

Tue, 10/1/24 - 10:25 pm

Tandem Diabetes

Roche targets more than $3 billion in annual obesity sales

Reuters

Mon, 09/30/24 - 10:09 am

Carmot Therapeutics

Cancer and diabetes drugs expected to dominate 2025 Medicare negotiations under IRA

BioSpace

Wed, 09/25/24 - 12:08 pm

Inflation Reduction Act

Bristol Myers Squibb

Lilly delivers one-two punch with 2nd tranche of positive data on weekly insulin candidate

Fierce Biotech

Wed, 09/11/24 - 11:07 pm

Eli Lilly says experimental insulin could mean 313 fewer injections per year

Quartz

Thu, 09/5/24 - 11:50 am

long-acting insulin

clinical trials

Merck and EyeBio launch trial of Restoret for diabetic macular edema

Clinical Trials Arena

Thu, 09/5/24 - 11:33 am

diabetic macular edema

Abbott launches over-the-counter continuous glucose monitor in the US

Reuters

Thu, 09/5/24 - 11:31 am

The Clearances & Approvals Keep Coming in Diabetes Tech

Medical Devices and Diagnostics Industry

Tue, 09/3/24 - 11:17 am

disposable patch insulin pump

Dexcom launches over-the-counter continuous glucose sensors in the US

Reuters

Mon, 08/26/24 - 10:11 pm

Lilly’s tirzepatide cuts diabetes risk, study data show

BioPharma Dive

Tue, 08/20/24 - 11:54 am

type 2 diabetes

clinical trials

Tandem warns iPhone app still draining insulin pump batteries

Medtech Dive

Thu, 08/15/24 - 10:27 pm

Tandem Diabetes

Abbott’s FreeStyle Libre CGM Meets Medtronic’s Insulin Delivery

Xtalks

Tue, 08/13/24 - 11:11 pm

Senseonics Looks to Stand Apart from the Big 3 in Diabetes Tech

Medical Devices and Diagnostics Industry

Mon, 08/12/24 - 05:54 pm

continuous glucose monitoring

Patients push back against Novo Nordisk move to scrap an insulin product

Reuters

Tue, 07/30/24 - 06:37 pm

long-acting insulin

As GLP-1 sales surge, insulin users fear Novo Nordisk and Eli Lilly will move on without them

Stat

Wed, 07/17/24 - 11:39 am

Novo Nordisk faces scrutiny on Capitol Hill for pulling Levemir insulin from US market

Reuters

Sun, 07/14/24 - 10:17 pm

Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts

Fierce Pharma

Fri, 07/12/24 - 11:33 am

FTC poised to sue drug middlemen over insulin prices

Axios

Fri, 07/12/24 - 11:30 am

Express Scripts

Ozempic's popularity leads to shortages for people with Type 2 diabetes

NPR

Wed, 07/10/24 - 11:01 am

Biden joins Sanders' campaign targeting Novo Nordisk, Eli Lilly's diabetes and obesity drug prices

Fierce Pharma

Tue, 07/2/24 - 11:46 am

Pages